Skip to main content
All lobbying filings

RED+BLUE STRATEGIES

Lobbying for DAVITA INC. · A leading provider of dialysis services in the United States.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $70,000.00 income · posted Apr 5, 2025

Official filing document

 Bills named in this filing 3
  • HR 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
  • S 891
    Bipartisan Health Care Act
  • HR 2199
    Restore Protections for Dialysis Patients Act
 Lobbying activity 2
Health Issues

H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies,such as CMS. S. 891 - The Bipartisan Health Care Act - Policies impacting the treatment of dialysis patients covered by government and private insurance. H.R. 2199 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with End Stage Renal Disease.

Medicare/Medicaid

H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies,such as CMS. S. 891 - The Bipartisan Health Care Act - Policies impacting the treatment of dialysis patients covered by government and private insurance. H.R. 2199 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with End Stage Renal Disease.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem